Related Experiment Video

Updated: Aug 21, 2026

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
09:37

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Published on: August 1, 2018

Cardiovascular problems in cirrhotic patients

Zeki Karasu1, Ayşe L Mindikoğlu, David H Van Thiel

  • 1Ege University Medical School, Izmir.

The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology
|October 20, 2004
PubMed

Insights

Cardiovascular diseases frequently coexist with chronic liver disease. Managing these conditions is crucial for patient outcomes, particularly for those awaiting liver transplantation.

Area of Science:

  • Hepatology
  • Cardiology
  • Internal Medicine

Background:

  • Chronic liver disease (CLD) is associated with significant cardiovascular complications.
  • Cardiovascular diseases (CVDs) can impact the progression and management of CLD.

Purpose of the Study:

  • To identify the associations between cardiovascular diseases and chronic liver disease.
  • To evaluate the effect of CVDs on the natural history of CLD.
  • To emphasize the importance of recognizing and managing CVDs in CLD patients.

Main Methods:

  • Literature review and synthesis of existing studies.
  • Analysis of epidemiological data on co-occurrence of CLD and CVD.
  • Clinical case reviews and outcome analysis.

Main Results:

  • Specific CVDs commonly observed in CLD patients were identified.
  • Evidence suggests CVDs can accelerate liver disease progression.
  • Timely diagnosis and treatment of CVDs improve long-term prognosis in CLD.

Conclusions:

  • Cardiovascular health is integral to the management of chronic liver disease.
  • Integrated care approaches are necessary for patients with coexisting CLD and CVD.
  • Management of CVDs is critical for liver transplant candidates.

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...